PARP1 and pulmonary arterial hypertension: Another clinical study showed that the levels of key factors involved in parthanatos, such as PARP‐1, PAR, AIF, and MIF, were significantly increased in PAH patients, particularly in non‐survivors,127 which underscores the connection between vascular parthanatos and PAH pathogenesis.